SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-199545
Filing Date
2018-06-21
Accepted
2018-06-21 16:32:35
Documents
6
Period of Report
2018-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d608225d8k.htm 8-K 28136
2 EX-10.1 d608225dex101.htm EX-10.1 106609
3 EX-10.2 d608225dex102.htm EX-10.2 45556
4 EX-10.3 d608225dex103.htm EX-10.3 38463
5 EX-10.4 d608225dex104.htm EX-10.4 44489
6 EX-10.5 d608225dex105.htm EX-10.5 41063
  Complete submission text file 0001193125-18-199545.txt   305683
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36274 | Film No.: 18912140
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences